Jeremy Hing
Dr Peter Wright
| Distinguishing animal subsets in toxicokinetic studies: Comparison of non-linear mixed effects modelling with non-compartmental methods | 2002 |
|
Dr William Wight
Dr Peter Wright
| Pharmacokinetics and pharmacodynamics of rapacuronium bromide | 2002 |
|
Dr Peter Wright
| Pharmacokinetics of propofol infusions in critically ill neonates, infants, and children in an intensive care unit | 2002 |
|
Dr Peter Wright
| A pharmacokinetic-dynamic explanation of the rapid onset-offset of rapacuronium | 2001 |
|
Jeremy Hing
Dr Peter Wright
| Analysis of toxicokinetic data using NONMEM: Impact of quantification limit and replacement strategies for censored data | 2001 |
|
Jeremy Hing
Dr Peter Wright
| Is mixed effects modeling or naive pooled data analysis preferred for the interpretation of single sample per subject toxicokinetic data? | 2001 |
|
Dr Peter Wright
| Pharmacokinetic studies of neuromuscular blocking agents: Good clinical research practice (GCRP) | 2000 |
|
Dr Peter Wright
| Rapacuronium 2.0 or 2.5 mg kg-1 for rapid-sequence induction: Comparison with succinylcholine 1.0 mg kg-1 | 2000 |
|
Dr Peter Wright
Jeremy Hing
| Temperature-dependent pharmacokinetics and pharmacodynamics of vecuronium | 2000 |
|
Dr Nitin Kumar
Dr Peter Wright
| A large simple randomized trial of rocuronium versus succinylcholine in rapid-sequence induction of anaesthesia along with propofol | 1999 |
|
Dr Peter Wright
| A pharmacodynamic explanation for the rapid onset/offset of rapacuronium bromide | 1999 |
|
Dr Peter Wright
| Influence of chronic phenytoin administration on the pharmacokinetics and pharmacodynamics of vecuronium | 1999 |
|
Dr Peter Wright
| Influence of renal failure on the pharmacokinetics and neuromuscular effects of a single dose of rapacuronium bromide | 1999 |
|
Dr Peter Wright
| Rapid onset/offset of rapacuronium bromide explained? Reply | 1999 |
|
